Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05679063
Other study ID # EndometriosisCdV2022
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date December 12, 2022
Est. completion date January 12, 2024

Study information

Verified date January 2023
Source University of Valladolid
Contact REBECA ABRIL, Doctoral Student
Phone 676434719
Email rebeca.abril@hotmail.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The objective of this study will be to evaluate treatment using ET exercise and pain education in women with endometriosis to achieve improvement in quality of life.


Description:

A study will be carried out whose objective is to improve the quality of life in women with endometriosis through a program of therapeutic exercise and education in the neurophysiology of pain. Also as secondary variables will be observed: menstrual symptoms, sexual function, and abdominal wall thickness measured with ultrasound.


Recruitment information / eligibility

Status Recruiting
Enrollment 60
Est. completion date January 12, 2024
Est. primary completion date October 12, 2023
Accepts healthy volunteers No
Gender Female
Age group 18 Years to 45 Years
Eligibility Inclusion Criteria: - Women of reproductive age between 18 and 45 years. - Women with a medical diagnosis of endometriosis. - Women with visual analog scale (EVA) between 4 and 10 (moderate-severe pain) during the last 3 months in the suprapubic area, abdomen or perineum both continuously and intermittently. Exclusion Criteria: - Women who must have surgery during the study. - Women who have undergone abdominal or pelvic surgery or who have given birth (vaginal or cesarean) in the last 6 months. - Women who are pregnant or planning a pregnancy. - Women with uncorrected pacemakers or coagulopathies, severe comorbid disorder, cancer (in the last 5 years or at present), severe mental disorders, or neuropathies affecting the nerves of the pelvis or lower extremities. - Physiotherapy treatments or treatments related to pathology or study areas 15 days prior to the beginning of the study. - Variations in medication in the 3 months prior to the start of the stud

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Physiotherapy
A program of therapeutic exercise and education in the neurophysiology of pain will be applied to the participants of the experimental group
Sham, Control
Talks about healthy habits

Locations

Country Name City State
Spain SBFisioterapia Soria

Sponsors (1)

Lead Sponsor Collaborator
University of Valladolid

Country where clinical trial is conducted

Spain, 

Outcome

Type Measure Description Time frame Safety issue
Primary Changes in quality of life perception assessed using EUROQuOL 5D - 5L The scale will be administered by one of the researchers, This scale covers five dimensions, each of which is assigned a score from 1 to 5, and with these scores, a code is obtained that indicates the person's quality of life. High values indicate poor quality of life. Baseline, Up to 1 month, Up to 3 months, Up yo 6 months.
Secondary Abdominal wall muscle thickness The muscle thickness of the abdominal wall with ultrasound according to a defined protocol. Baseline, Up to 1 month, Up to 3 months, Up to 6 months.
Secondary Sexual Function assessed usinf Female Sexual Function Index (IFSF) The scale will be administered by one of the researchers. This questionnaire consists of 19 questions and is grouped into six domains: desire, arousal, lubrication, orgasm, satisfaction, and pain; each question has 5 or 6 options, assigning them a score ranging from 0 to 5. The score for each domain is multiplied by a factor and the result final is the arithmetic sum of the domains. A higher score better sexuality Baseline, Up to 1 month, Up to 3 months, Up to 6 months.
Secondary Symptoms associated with menstruation assessed using CVM-22 (quality of life related to menstruation) The scale will be administered by one of the researchers. Minimin value = 0. Maximum value = 66. A high result indicates a good quality of life-related to menstruation Baseline, up to 1 month, up to 3 months, up to 6 months.
See also
  Status Clinical Trial Phase
Completed NCT01931670 - A Global Phase 3 Study to Evaluate the Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain Phase 3
Recruiting NCT05648669 - A Study to Evaluate Safety and Efficacy of Elagolix in Patients With Moderate to Severe Endometriosis-Associated Pain Phase 3
Completed NCT04081532 - The Effectiveness of Laparoscopic Treatment of Superficial Endometriosis for Managing Chronic Pelvic Pain N/A
Recruiting NCT06101303 - Endometriosis Pain
Completed NCT04665414 - Diagnosis of Adenomyosis Using Ultrasound, Elastography and MRI
Completed NCT03690765 - Study of Real Clinical Practice to Evaluate the Effects of Oral Dydrogesterone for Treatment of Confirmed Endometriosis
Recruiting NCT05153512 - ADOlescent DysmenoRrhea Endometriosis Assessment Magnetic Resonance Imaging (Adodream)
Active, not recruiting NCT04171297 - Ultrasound Evaluation of the Pelvis in Women With Suspected Endometriosis Scheduled for Laparoscopic Surgery
Recruiting NCT04172272 - The Influence of TAP Block in the Control of Postoperative Pain After Laparotomy for Gynecological Procedures N/A
Completed NCT04565470 - Strategies of Self-management of Endometriosis Symptoms
Completed NCT03613298 - Treatment by HIFU With Focal One® of Posterior Deep Infiltrating Endometriosis Lesions With Intestinal Involvement. N/A
Withdrawn NCT05568940 - Evaluating Tibolone Add-back in Patients With Endometriosis and Fibroids
Not yet recruiting NCT03464799 - Does Immunotherapy Have a Role in the Management of Endometriosis?
Active, not recruiting NCT03002870 - Characteristics of Patient Population With Endometriosis N/A
Withdrawn NCT03272360 - Endometriosis Biomarker Discovery Study N/A
Completed NCT02973854 - Activation of the Sphingosine-1-phosphate (S1P) to S1P1 Receptor Subtype (S1PR1) Axis in Patients With Endometriosis: Identification of Potential Relevant Biomarkers to Diagnose and Treat
Recruiting NCT02481739 - Laparoscopic Surgical Management of Endometriosis on Fertility N/A
Active, not recruiting NCT02754648 - Three Different Laparoscopic Approaches for Ovarian Endometrioma and the Effect on Ovarian Reserve N/A
Completed NCT06106932 - GnRH-a on Angiogenesis of Endometriosis N/A
Completed NCT02387931 - Supplementation in Adolescent Girls With Endometriosis Phase 4